docs (beta)

42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen 
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1010051
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record 
Array
(
    [id] => 4cf7cf4d-0669-41d9-a68a-badaeac01dca
    [Document ID] => 1010051
    [Document naam] => RE: toculizumab - al zicht op indiening indicatie-uitbreiding?
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/document/VWS-WOO-08-1010051
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1010051
    [Status] => shiningstar
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO
    [DocumentPublicationDate] => 1 december 2020
    [DocumentStatusCheckedDate] => 2026-04-28 02:04:19.49238
    [DocumentStatusCheckedResult] => 200
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 04:28:20
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 04:28:20
)

Document: VWS-WOO-08-1010051

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20201201

Geregistreerde documentnaam: RE: toculizumab - al zicht op indiening indicatie-uitbreiding?

Document metadata

Metadata tonen (25 velden)
VeldWaarde
id4cf7cf4d-0669-41d9-a68a-badaeac01dca
Document ID1010051
Document naamRE: toculizumab - al zicht op indiening indicatie-uitbreiding?
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/document/VWS-WOO-08-1010051
Opgeschortleeg!
Definitief IDVWS-WOO-08-1010051
Statusshiningstar
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO
DocumentPublicationDate1 december 2020
DocumentStatusCheckedDate2026-04-28 02:04:19.49238
DocumentStatusCheckedResult200
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 04:28:20
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 04:28:20

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
Request_Omvang publicatie10.222 documenten waarvan 3.750 openbaar gemaakt Inventarislijst2026-03-11 05:32:32
Request_Omvang publicatie_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/file/download/inventory2026-03-11 05:32:32
Request_Omvang publicatie_paginas10.2222026-03-11 05:32:32
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2026-03-11 05:32:32
document_SectionDownloadButton12026-03-11 05:32:32
Request_Omvang publicatie_linkname_1Inventarislijst2026-03-11 05:32:32
About_Gelakte gegevens_linkhref_2mailto:DienstpostbusDatalekkenDoo@minvws.nl2026-03-11 05:32:32
About_Type bronbestandE-mailbericht, 1 pagina's2025-06-22 23:38:08
About_Type bronbestand_paginas12025-06-22 23:38:08
About_Download alsPDF (468.51 KB)2025-06-22 23:38:08
About_Documentnummer10100512025-06-22 23:38:08
About_BeoordelingGedeeltelijke openbaarmaking2025-06-22 23:38:08
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:38:08
About_Gelakte gegevens_linkname_15.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-22 23:38:08
About_Gelakte gegevens_linkname_2Laat het ons weten2025-06-22 23:38:08
document_SectionAttachments12025-06-22 23:38:08
document_SectionRequest12025-06-22 23:38:08
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode december 20202025-06-22 23:38:08
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO2025-06-22 23:38:08
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode december 20202025-06-22 23:38:08
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 7 juli 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode december 2020.2025-06-22 23:38:08
Request_PeriodeDecember 20202025-06-22 23:38:08
Request_Type besluitWoo-besluit2025-06-22 23:38:08
Request_Datum besluit7 juli 20222025-06-22 23:38:08
document_SectionHistory12025-06-22 23:38:08
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-22 23:38:08
document_documentNameRE: toculizumab - al zicht op indiening indicatie-uitbreiding?2025-06-22 23:38:08
document_documentTypeE-mailbericht2025-06-22 23:38:08
document_documentPublicationDate2020-12-012025-06-22 23:38:08
document_documentNumberVWS-WOO-08-10100512025-06-22 23:38:08
document_SectionAbout12025-06-22 23:38:08
About_Datum document1 december 20202025-06-22 23:38:08
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-22 23:38:08
About_Gelakte gegevens_linkhref_2mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over RE: toculizumab - al zicht op indiening indicatie-uitbreiding? (documentnummer 1ee69440-3874-6cf4-94a8-bb525e933826)2025-06-22 23:38:08
Request_Omvang openbaarmaking10.222 documenten, 13.478 pagina's Inventarislijst2025-06-22 23:38:08
Request_Omvang openbaarmaking_documenten10.2222025-06-22 23:38:08
Request_Omvang openbaarmaking_paginas13.4782025-06-22 23:38:08
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/file/download/inventory2025-06-22 23:38:08
document_SectionHTMLDataDivs42025-06-22 23:38:08
document_SectionDownloadButton02025-06-22 23:38:08
History Actie_2Opschorting opgeheven2025-06-21 03:16:39
History Datum_228 augustus 2024 15:132025-06-21 03:16:39
History Actie_1Bronbestand toegevoegd (pdf, 468.51 KB)2025-06-21 03:16:39
History Datum_128 augustus 2024 15:192025-06-21 03:16:39
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1010051.pdf2025-04-20 00:17:02
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3395155-1032354-PDO/file/download/document/1ee69440-3874-6cf4-94a8-bb525e9338262025-04-20 00:17:02
DocumentDownload_linknameDownload (pdf, 468.51 KB)2025-04-20 00:17:02

Archiefversies (8 rijen)

Archiefrij 1 — 2025-11-21 15:41:07
fromFile: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341871
documentSize: 479751
documentCompressRatio: 71.26009117229563
documentDateModified: 2025-10-09 12:59:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:41:07
lastSeen: 2025-11-21 15:41:07
text: 1010051 To: A. @minvws.nl @minvws.nl]; Cc: From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab EE TFS RET cg meb.ni] al zicht op indiening indicatie-uitbreiding? Tue 12/1/2020 1:05:56 PM Received: - FW: Resultaten EMPACTA studie met tocilizumab.eml Dank voor je bericht. Bijg...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b517e0e854bcef371a9bcfdf3ed44cfdc280e7eadd784007d0c23e80eadd77df
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: d355f091-555a-46ab-b40a-f1ce93b654ca
textDigestSHA256: 6fce96b9d3b9be27efda7757f70416d796cb1d2fbce91d93d4d8f80a5344efb4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 2 — 2025-11-21 15:38:42
fromFile: VWS-WOO-3395155-1032354-PDO-1f0a50fa-40da-605c-8681-b52ef042b7e3.zip
fromFilePath: archieven_files\VWS-WOO-3395155-1032354-PDO-1f0a50fa-40da-605c-8681-b52ef042b7e3.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341871
documentSize: 479751
documentCompressRatio: 71.26009117229563
documentDateModified: 2025-10-09 12:59:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:38:42
lastSeen: 2025-11-21 15:38:42
text: 1010051 To: A. @minvws.nl @minvws.nl]; Cc: From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab EE TFS RET cg meb.ni] al zicht op indiening indicatie-uitbreiding? Tue 12/1/2020 1:05:56 PM Received: - FW: Resultaten EMPACTA studie met tocilizumab.eml Dank voor je bericht. Bijg...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b517e0e854bcef371a9bcfdf3ed44cfdc280e7eadd784007d0c23e80eadd77df
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: eb5eb429-e58c-4321-8791-3929a0bc0589
textDigestSHA256: 6fce96b9d3b9be27efda7757f70416d796cb1d2fbce91d93d4d8f80a5344efb4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 3 — 2025-09-07 17:20:14
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1010051.pdf
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 479751
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:20:14
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:20:14
lastSeen: 2025-09-07 17:20:14
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b517e0e854bcef371a9bcfdf3ed44cfdc280e7eadd784007d0c23e80eadd77df
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_17727_fd11eb6ce6b4544082250216ed926108
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 4 — 2025-09-04 16:57:59
fromFile: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.1.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341871
documentSize: 479751
documentCompressRatio: 71.26009117229563
documentDateModified: 2025-05-01 20:26:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:57:59
lastSeen: 2025-11-21 13:47:41
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b517e0e854bcef371a9bcfdf3ed44cfdc280e7eadd784007d0c23e80eadd77df
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3395155-1032354-PDO-1f026c98-53dc-609a-93c3-65673e0af118.zip_2728
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 5 — 2025-03-18 09:30:24
fromFile: 2024.075-VWS-WOO-3395155-1032354-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3395155-1032354-PDO.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341125
documentSize: 479751
documentCompressRatio: 71.10459384138855
documentDateModified: 2024-12-17 13:52:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:24
lastSeen: 2025-03-18 09:30:24
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 319403
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 6 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3395155-1032354-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3395155-1032354-PDO.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341125
documentSize: 479751
documentCompressRatio: 71.10459384138855
documentDateModified: 2024-12-17 13:52:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
documentMailAdresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
digestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 231957
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 7 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3395155-1032354-PDO-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3395155-1032354-PDO-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
documentName: VWS-WOO-08-1010051.pdf
documentType: pdf
documentCompressedSize: 341125
documentSize: 479751
documentCompressRatio: 71.10459384138855
documentDateModified: 2024-12-17 13:52:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
documentMailAdresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
digestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 104989
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Archiefrij 8 — 2025-02-18 12:18:07
fromFile: Besluit__dossier_nr_-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-d7752f380f706321efde95609910f257ba07e3e396a74008abfad53e0fb845a2.zip
documentName: VWS-WOO-08-1010051-RE_toculizumab_-_al_zicht_op_indiening_indicatie-uitbreiding.pdf
documentType: pdf
documentCompressedSize: 341125
documentSize: 479751
documentCompressRatio: 71.10459384138855
documentDateModified: 2024-08-28 15:24:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:07
lastSeen: 2025-02-18 12:18:07
text: 1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg meb.ni] From: Sent: Tue 12/1/2020 1:05:51 PM Subject: RE: toculizumab-alzicht opindiening indicatie-uitbreiding? Received:Tue 12/1/2020 1:05:56 PM FW: Resultaten EMPACTA studie met tocilizumab.eml Dankvoor jebericht. Bijgevoegd delaatste info diew...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
documentMailAdresses: [{"position": 11, "email": "A.@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET"}, {"position": 27, "email": "@minvws.nl", "context": "1010051 To:A.@minvws.nl Cc:@minvws.nl]; EETFS RET cg"}, {"position": 654, "email": "@cbg-meb.nl", "context": "1december 2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp:"}, {"position": 667, "email": "@minvws.ni", "context": "2020 11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht"}, {"position": 690, "email": "@cbe-meb.ni", "context": "11:11 @cbg-meb.nl> @minvws.ni>;[ICAI<IEXE @cbe-meb.ni> Onderwerp: toculizumab-alzicht opindiening"}]
digestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 79972
textDigestSHA256: d92ff872560ebd672d545c69a18ba8286bcef850689a1f94b4cad5487f291055
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1010051
Nieuw document zoeken

(dit is ook een speeltuin)